China’s State FDA Says Merck Recalled Meningitis Vaccine (China)
This article was originally published in PharmAsia News
China's State FDA says U.S. drug maker Merck has recalled its Pedvaxhib (haemophilus b) conjugate vaccine for preventing meningitis and other diseases because of a sterilization problem in one of its U.S. factories. Merck said it recalled Pedvaxhib and similar Comvax vaccines after it discovered the sterilization problem in its Pennsylvania factory. No cases of children receiving Hib for preventing meningitis, pneumonia and other infections were reported, although infections usually take at least a week to develop. Hib is combined with a hepatitis B vaccine to prevent the other diseases. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.